The specific use of budesonide in the treatment of allergic rhinitis
https://doi.org/10.21518/2079-701X-2016-07-82-85
Abstract
The article tells about the epidemiology, etiology and pathogenesis of allergic rhinitis. The focus is on the treatment of allergic rhinitis, the leading role of topical corticosteroids in the treatment of rhinitis, and the specific use of budesonide.
About the Author
S. V. Tsarev
Institute of immunology of the Federal Medical and Biological Agency of Russia (FMBA), Moscow
Russian Federation
MD
Russian Federation
MD
References
1. Богова А.В., Ильина Н.И., Лусс Л.В. Тенденции в изучении эпидемиологии аллергических заболеваний в России за последние 10 лет. Российский аллергологический журнал, 2008, 6: 3-14.
2. Ревякина В.А. Эпидемиология аллергических заболеваний у детей и организация педиатрической аллергологической службы в России. Педиатрия, 2003, 4: 47-52.
3. Польнер С.А., Козаренко Е.А., Шевцов Е.А. Целесообразность и место риносептопластики в комплексном лечении аллергического ринита и бронхиальной астмы. Цитокины и воспаление, 2012, 12(3): 130-132.
4. Шартанова Н.В., Царев С.В., Цывкина А.А и др. Особенности аллергического статуса у спортсменов высших достижений. Российский аллергологический журнал, 2012, 1(1): 345-346.
5. Hopper JL, Jenkins MA, Carlin JB et al. Increase in the self-reported prevalence of asthma and hay fever in adults over the last generation: a matched parent-offspring study. Aust J Public Health, 1995, 19: 120-124.
6. Bousquet J, Khaltaev N, Cruz AA et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy, 2008, 63: 8-160.
7. Kern R. Allergy: a constant factor in the etiology of so-called mucous nasal polyps. J Allergy, 1993, 4: 483.
8. van Cauwenberge P et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy, 2000, 55(2): 116-134.
9. Brozek JL, Bousquet J, Baena-Cagnani CE et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision. J Allergy Clin Immunol, 2010, 126(3): 466-476 .
10. Schafer T, Schnoor M, Wagenmann M, Klimek L, Bachert C. Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis. Rhinology, 2011, 49: 272-280.
11. Pipkorn U, Pukander J, Suonpää J et al. Longterm safety of budesonide nasal aerosol: a 5.5- year follow-up study. Clin Allergy, 1988, 18(3): 253-259.
12. Möller C, Ahlström H, Henricson K-A et al. Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis. Clinical & Experimental Allergy, 2003, 33(6): 816-22.
13. Fokkens WJ, Cserháti E, Lopes Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours. Annals of Allergy, Asthma & Immunology, 2002, 89(3): 279-284.
14. Lund VJ, Black JH, Szabó LZ, et al. Efficacy and tolerability of budesonide aqueous nasal spray in chronic rhinosinusitis patients. Rhinology, 2004, 42(2): 57-62.
Review
For citations:
Tsarev SV. The specific use of budesonide in the treatment of allergic rhinitis. Meditsinskiy sovet = Medical Council. 2016;(7):82-85. (In Russ.) https://doi.org/10.21518/2079-701X-2016-07-82-85
Views:
720
Email this article 